NSE filing, NSE: NAVA. Summary written from the filing by ALFA Finder's alert engine.
NAVA Ltd: key numbers
- Share price
- ₹501.50
- Market cap
- ₹14,209 Cr
- Revenue (annual)
- ₹4,291 Cr
- Net profit (annual)
- ₹786.7 Cr
- P/E (TTM)
- 18.8×Sector 21.0×
- Promoter holding
- 50.03%+0.00% QoQ
- FII holding
- 9.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NAVA Ltd
All →NAVA Other Announcement
Nava Ltd disclosed that employee Bhagam Rama Rao acquired 10,000 equity shares via ESOP on 16-Oct-2026. This is a routine PIT Reg 7(2) compliance filing with no material corporate decision.
NAVA Employee Stock Options
Nava Limited allotted 23,550 equity shares upon exercise of vested RSUs to eligible employees, realizing ₹1.17 Crore from the exercise.
- Value
- ₹1.17 Cr
NAVA Other Announcement
Nava Limited submitted the RTA's certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
NAVA Promoter Selling (Off-Market)
Nava Ltd's promoter group member TRIVIKRAMA PRASAD PINNAMANENI HUF disposed of 1,01,000 equity shares via an off-market transfer. The disposal was executed under a partition deed to a relative.
NAVA Production Started
Nava Limited commissioned its 100 MW solar plant in Zambia, with grid power evacuation commenced. A 20-year PPA with ZESCO marks the group's renewable energy entry.
- solar capacity
- 100 MW
NAVA Promoter Buying: ₹0.83 Cr
Promoter Group entity AV Dwellings Private Limited purchased 15,000 equity shares of Nava Ltd via open market, valued at ₹0.83 Crore.
- Value
- ₹0.83 Cr
- Promoter stake change
- +0.01%
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date